Today’s AI Top Pick: PGY

9/30/2026 · Highly Shorted Turnaround Deep Rotation screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

The desk streams live daily· see the schedule →

Measured weekly model accuracy · PGY72%36 resolved forecasts · 60d window · verify →

Today's pick · Highly Shorted Turnaround Deep RotationPGYBUY NOW8.0 / 109/30/2026

Pagaya Technologies is the best risk-adjusted entry in this pool because it uniquely combines a strong fundamental score (8.0, the joint-highest alongside TOYO) with clean multi-timeframe confirmation and a positive news catalyst. On the tape, the 4h, 1d, and 1wk all show bullish forecast bias across short/mid/long horizons (fc_short ~42-44%, fc_mid ~43-44%, fc_long ~44-48%), and the stock sits just 6.69% off its 21-bar daily high and 45.4% off its weekly high — meaning it is NOT chasing a top, it has room to run. The 1d drawdown of -24.28% is a healthy shakeout, not a breakdown. Bullish probability is 1.0, and near-term bullish is 0.8. Fundamentally, PGY is the standout: P/E of 13.43, a rock-bottom PEG of 0.14, forward P/E of just 7.49, ROE of 26.39%, operating margin of 22.87%, and EPS growth next year of 38.72% — all while carrying a 15.63% short float that provides squeeze fuel. Short Float ≥15%, 1Y performance -45.31% (≤-20%), EPS growth ≥20%, and analyst Recom of 1.0 (strong buy) all clear the screen. Target upside of 68.4% is real and supported. The news block is a decisive tiebreaker in PGY's favor: StoneX reiterated a Buy with a $33 price target (well above current ~$17.40), and the company just secured its first Variable Funding Note Facility with ATLAS SP Partners — a concrete committed-capital win that directly de-risks the balance sheet. The only blemish is a minor insider sale (CAO sold 2,170 shares), which is routine and far outweighed by the buy-side analyst support. Unlike MNDY (getting obliterated intraday) or KVYO (director selling, still expensive at fwd P/E 14.42), PGY has both the tape and the catalyst aligned. TODAY is the right entry because the setup is confirmed across all timeframes, the stock is mid-range (not extended), and a fresh capital facility + reiterated buy rating provide near-term momentum before any re-rating completes.

Entry zone

Buy on dips into $16.60-$17.40 (current ~$17.40; 4h support zone). Add on any pullback to the $16.00 psychological/technical level.

Stop loss

Hard stop below $15.10 (below the -24% daily drawdown low and 21-bar range floor). Exit if daily closes under $15.

First target

$21.00 (near-term re-rating toward StoneX $33 target trajectory, ~20% upside)

Longer target

$33.00 (StoneX price target, ~90% upside on the swing trade)

Risks

Short float of 15.63% provides squeeze upside but also means elevated volatility and short-seller risk if a bearish report emerges.
Debt-to-equity of 1.58 is elevated for a tech name, and Pagaya's funding-facility model is sensitive to capital-market conditions.
Minor insider selling (CAO Cory Vieira sold 2,170 shares on 2026-09-30) — small but worth watching for pattern.
Earnings of PGY are lumpy and tied to its AI/data licensing pipeline; a soft pipeline update could trigger a sharp drawdown beyond the stop.
Small-cap ($1.45B) with thinner liquidity — larger entries could move the price against you.

Honorable mentions

MIRStrong #2: bullish_prob 1.0, near_term_bullish 1.0, and a fresh Buy upgrade from Yahoo on 2026-09-29. The 4h/1d/1wk all show bullish forecast bias. However, the 'slow backlog conversion dampens profit outlook' headline is a landmine, and the extreme P/E of 162.59 with fwd P/E 21.48 makes valuation stretched versus PGY's 7.49.

KVYOStrong #3: bullish_prob 1.0, near_term_bullish 1.0, and a compelling PEG of 0.56 with 74.2% target upside. But the P/E of 719.34 is extreme, a director just sold shares, and the 1d timeframe shows no data — less multi-timeframe confirmation than PGY.

AMRCSolid #4: bullish_prob 1.0, near_term_bullish 0.8, and a positive catalyst (Army nuclear/power lease talks, 65% undervalued call). But the 1wk forecast turns negative (fc_long -23.74%) and the 1d pos_in_range of only 12.31% signals a weaker trend than PGY's multi-frame alignment.

WINGBUY_PULLBACK. bullish_prob 1.0, near_term_bullish 1.0, strong operating margin (28.77%) and 83.6% target upside. But the 1d timeframe shows no data and the 1wk fc_long of -81.72% is a deep bearish tail; wait for a cleaner multi-frame setup.

ADTNBUY_PULLBACK. Highest expected return (95.96%) and EPS growth of 101.73%, plus a positive AI-infrastructure catalyst (OIF ECOC 2026 demo). But near_term_bullish is only 0.6, both available timeframes show -50%+ drawdowns, and consensus is now just 'Hold' — wait for stabilization.

PHATBUY_PULLBACK. bullish_prob 1.0, near_term_bullish 0.8, and a genuine positive catalyst (Phase 3 study initiation for VOQUEZNA). But negative profit margin (-41.34%), no P/E, and a -37% weekly drawdown make this a higher-risk biotech lottery ticket.

VCBUY_PULLBACK. near_term_bullish 1.0, low P/E 15.87, PEG 0.45, and 48.2% target upside. But salesYoY is -1.13% (declining revenue) and all three timeframes show drawdowns with fc_long turning negative; wait for revenue inflection.

TOYOWAIT. Joint-highest fundamental score (8.0) with a $240M solar supply agreement catalyst and PEG of 0.02. But short float of 47.14% is extreme (double-edged), the 1wk fc_long is -72.72% (deep bearish), and guidance was explicitly declined — wait for clarity.

CELHWAIT. near_term_bullish only 0.2, P/E of 119.85 is stretched, and 'fully priced on its earnings story' is a caution. Strong salesYoY of 82.86% but the tape is weak across all timeframes.

PATKWAIT. near_term_bullish 0.8, low P/E 16.44, but both timeframes show deep drawdowns (-25.84% 4h, -14.98% 1d) and fc_long turning negative; wait for trend stabilization.

TMDXBUY_PULLBACK. bullish_prob 1.0, insider buying ($109K by director David Weill), strong ROE 36.28%. But the 1d fc_long is only 24.23% and near_term_bullish is 0.6; wait for stronger multi-frame confirmation.

TPBWAIT. near_term_bullish 0.8, PEG 8.34 is stretched, and the stock was 'sliding this week.' Strong EPS growth (54.51%) but the tape shows -32% drawdowns across timeframes.

HROWWAIT. Moderate Buy rating and 105% upside target, but P/E is negative, ROE of -114.8% is deeply broken, and all timeframes show drawdowns. Wait for profitability confirmation.

GRRRWAIT. StoneX Buy with $25 target and a Taiwan AI contract are positive, but bullish_prob is only 0.2, profit margin is -35.38%, and near_term_bullish is 0.4. Wait for margin improvement.

ZENAWAIT. Explosive salesYoY of 530.37% and a defense quantum-navigation catalyst, but ROE of -137.81%, negative margins, and bullish_prob 1.0 with near_term_bullish only 0.4. High-risk narrative play, wait for profitability.

BTDRWAIT. Positive AI-cloud off-take catalyst and 35.3% short float, but near_term_bullish only 0.2, profit margin -55.15%, and fc_long negative on the weekly. Wait for margin stabilization.

INOWAIT. Oct 30 FDA PDUFA decision is a binary catalyst (EPS growth 44.1%), but all metrics negative (ROE -409.87%), no P/E, and near_term_bullish only 0.4. Wait for FDA decision clarity.

HIVEWAIT. Near_term_bullish 0.6 and AI growth narrative, but negative margins (-98.51%), fc_short at 0 on the 4h (no bullish bias), and crypto-correlated. Wait for margin improvement.

GLXYWAIT. bullish_prob is null (no signal), CEO Novogratz AI pivot is a double-edged catalyst, and near_term_bullish is null. Wait for a confirmed multi-frame setup.

ABTCAVOID. bullish_prob only 0.2, near_term_bullish 0, ROE -58.97%, and 'shares down 6.4% - time to sell?' is a caution. Bitcoin-linked but weak relative strength. Avoid until trend turns.

ARDTAVOID. bullish_prob 0, near_term_bullish 0, and a negative catalyst (St. Francis campus ownership transition). Recom of 2.0 (hold) and BMO Market Perform. Broken setup.

PDYNAVOID. near_term_bullish 0.8 but profit margin -254.75%, all timeframes showing drawdowns, and fc_long negative on the weekly. Speculative with weak fundamentals. Avoid until profitability.

KULRAVOID. near_term_bullish only 0.2, profit margin -607.64%, all timeframes showing drawdowns, and a material 8-K event. Broken fundamentals. Avoid.

TSSIAVOID. near_term_bullish only 0.4, fc_short negative on both timeframes (-45.87% 4h), salesYoY -26.52%, and fc_long negative. Broken trend. Avoid.

Full ranking (29)

#	Symbol	Verdict	Score	Read
1	PGY	BUY NOW	8.0	Joint-highest fundamental score (8.0), clean multi-frame bullish forecast, mid-range entry, and a fresh capital facility + StoneX Buy rating make this the best risk-adjusted buy today.
2	MIR	BUY PULLBACK	6.3	Bullish_prob 1.0 with a fresh Buy upgrade, but extreme P/E of 162.59 and a backlog-conversion landmine warrant a pullback entry.
3	KVYO	BUY PULLBACK	7.5	Bullish_prob 1.0 with a compelling PEG of 0.56, but P/E of 719.34 and insider selling call for patience.
4	AMRC	BUY PULLBACK	6.5	Army lease catalyst and 65% undervaluation are compelling, but the 1wk forecast turns negative and the 1d trend is weak.
5	PSIX	BUY PULLBACK	6.8	Strong ROE of 40.07% and near_term_bullish 0.8, but the 1d fc_long is deeply negative (-51.88%) and RSI of 65.53 is approaching overbought.
6	WING	BUY PULLBACK	6.0	Bullish_prob 1.0 with 28.77% operating margin and 83.6% target upside, but the 1wk fc_long of -81.72% argues for waiting.
7	ADTN	BUY PULLBACK	5.8	Highest expected return (95.96%) with an AI-infrastructure catalyst, but -50%+ drawdowns and a 'Hold' consensus demand caution.
8	CELH	WAIT	5.5	Explosive salesYoY of 82.86%, but P/E of 119.85 and near_term_bullish of only 0.2 make this a wait.
9	TMDX	BUY PULLBACK	5.0	Insider buying and ROE of 36.28% are positive, but multi-frame confirmation is incomplete and near_term_bullish is only 0.6.
10	PATK	WAIT	5.0	Low P/E of 16.44 with near_term_bullish 0.8, but deep drawdowns and negative fc_long argue for waiting.
11	ARDT	AVOID	5.0	Bullish_prob 0, near_term_bullish 0, and a campus-ownership landmine make this a broken setup.
12	TPB	WAIT	3.8	Strong EPS growth of 54.51% but PEG of 8.34 and a sliding tape call for patience.
13	AREC	WAIT	3.3	Blackion acquisition LOI is a catalyst, but negative margins and a -37% weekly drawdown demand caution.
14	GENI	WAIT	3.3	Brazil regulatory overhang weighs on an otherwise positive setup; wait for clarity.
15	HROW	WAIT	2.5	105% upside target but deeply negative ROE (-114.8%) and no positive P/E — wait for profitability.
16	PHAT	BUY PULLBACK	4.8	Phase 3 catalyst is real, but -41% profit margin and a -37% weekly drawdown make this a lottery ticket.
17	GRRR	WAIT	1.3	StoneX Buy and Taiwan AI contract are positive, but bullish_prob of only 0.2 and -35% margins call for waiting.
18	ZENA	WAIT	2.3	530% salesYoY growth is explosive but ROE of -137.81% and negative margins make this a high-risk wait.
19	ABTC	AVOID	2.3	Bullish_prob of only 0.2, near_term_bullish 0, and weak relative strength make this an avoid.
20	TNXP	WAIT	2.3	Medicare payer agreements are positive but ROE of -81.82% and -30% drawdowns demand caution.
21	HIVE	WAIT	1.5	AI narrative is intact but -98% margins and a 0 fc_short on the 4h signal a weak tape.
22	BTDR	WAIT	1.5	AI-cloud catalyst is real but -55% margins and near_term_bullish of 0.2 call for waiting.
23	PDYN	AVOID	2.3	FANUC collaboration is positive but -254% margins and negative fc_long make this an avoid.
24	KULR	AVOID	2.3	Material 8-K and -607% margins with a weak tape make this an avoid.
25	INO	WAIT	2.0	Oct 30 FDA decision is a binary catalyst but all fundamentals are negative — wait for the decision.
26	GLXY	WAIT	2.3	Null bullish_prob and null near_term_bullish mean no confirmed setup — wait.
27	TOYO	WAIT	8.0	Joint-highest fundamental score (8.0) with a $240M catalyst but a 47% short float and -72% weekly fc_long demand waiting.
28	TSSI	AVOID	4.3	Negative fc_short across timeframes and -26% salesYoY make this a broken trend to avoid.
29	VC	BUY PULLBACK	6.0	Low P/E and near_term_bullish 1.0 are attractive but declining salesYoY (-1.13%) and negative fc_long call for a pullback entry.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord